» Articles » PMID: 20607418

Lymph-vascular Space Invasion As a Significant Risk Factor for Isolated Para-aortic Lymph Node Metastasis in Endometrial Cancer: a Study of 203 Consecutive Patients

Overview
Journal Ann Surg Oncol
Publisher Springer
Specialty Oncology
Date 2010 Jul 8
PMID 20607418
Citations 12
Authors
Affiliations
Soon will be listed here.
Abstract

Background: The purpose of this study was to investigate various pathologic risk factors associated with para-aortic lymph node metastasis (LNM) in surgically staged patients with endometrial cancer.

Materials And Methods: We performed a retrospective analysis of 203 consecutive patients with endometrial cancer who were surgically staged from 2000 to 2009. The association among the various pathologic variables for para-aortic LNM was determined with univariate and multivariate analyses.

Results: Of 203 patients, 29 patients (14.3%) had LNM. Also, 10 patients (4.9%) had only pelvic LNM, 14 (6.9%) had both pelvic and para-aortic LNM, and 5 (2.5%) had para-aortic LNM without pelvic LN involvements. Histologic type (P = .001), tumor grade (P < .001), tumor size (P = .003), depth of myometrial invasion (P < .001), cervical invasion (P < .001), parametrial invasion (P = .002), lymph-vascular space invasion (LVSI) (P < .001), serosal/adnexal invasion (P < .001), positive cytology (P = .002), peritoneal seeding (P < .001), and pelvic LNM (P < .001) were significant pathologic factors for para-aortic LNM. On multivariate analysis, cervical invasion (P = .032), LVSI (P = .018), and positive pelvic LNs (P = .002) were independent factors for para-aortic LNM. With regard to isolated para-aortic LNM, tumor grade (P = .017) and LVSI (P = .002) were significant factors for LN involvements. On multivariate analysis, LVSI (P = .004) was the only significant independent factor.

Conclusions: LVSI correlates significantly with the risk of isolated para-aortic LNM in endometrial cancer patients.

Citing Articles

Paraaortic lymph node metastasis in endometrial cancer patients: a comprehensive analysis of rates, survival outcomes, and risk factors through systematic review and meta-analysis.

Han L, Chen Y, Zheng A, Tan X, Chen H Front Oncol. 2024; 14:1490347.

PMID: 39544303 PMC: 11561408. DOI: 10.3389/fonc.2024.1490347.


Real-World Data Assessing the Impact of Lymphovascular Space Invasion on the Diagnostic Performance of Sentinel Lymph Node Mapping in Endometrial Cancer.

Buechi C, Siegenthaler F, Sahli L, Papadia A, Saner F, Mohr S Cancers (Basel). 2024; 16(1).

PMID: 38201495 PMC: 10778553. DOI: 10.3390/cancers16010067.


Non-endometrioid endometrial cancer: analysis of recurrence pattern and identification of prognostic and treatment factors affecting recurrence and survival.

Lee S, Kang H, Kwak Y, Kim M, Kim J Strahlenther Onkol. 2023; 199(9):828-837.

PMID: 36930247 DOI: 10.1007/s00066-023-02061-1.


Surgical restaging of patients with early‑stage endometrial cancer with lymphovascular invasion does not significantly impact their survival outcomes.

Navarro B, Margioula-Siarkou C, Petousis S, Floquet A, Babin G, Guyon F Oncol Lett. 2023; 25(3):122.

PMID: 36844624 PMC: 9950339. DOI: 10.3892/ol.2023.13708.


Association of Tumor Size With Myometrial Invasion, Lymphovascular Space Invasion, Lymph Node Metastasis, and Recurrence in Endometrial Cancer: A Meta-Analysis of 40 Studies With 53,276 Patients.

Jin X, Shen C, Yang X, Yu Y, Wang J, Che X Front Oncol. 2022; 12:881850.

PMID: 35719999 PMC: 9201106. DOI: 10.3389/fonc.2022.881850.